Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe most common side effects of taking semaglutide are gastrointestinal: nausea, vomiting, diarrhoea and constipation. They affect the majority of people at some point during treatment, are usually mild to moderate, and tend to settle within days to a couple of weeks of starting or increasing the dose. Semaglutide is a prescription-only medicine — a prescriber assesses your full health picture before it is ever dispensed, and that conversation is the right place to set your personal expectations. If you want the fuller picture before that conversation, read on.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide slows the rate at which the stomach empties food into the small intestine. That is central to how it reduces appetite, but it is also why the gut takes time to adapt. In the first few weeks of treatment, nausea is the side effect most people notice first. It is rarely constant; many people describe it as arriving in waves, often in the hour or two after the injection, and then lifting. Vomiting is less common than nausea and, for most, does not become a regular feature.
Loose stools and diarrhoea sit at one end of the spectrum; constipation sits at the other. Both happen, sometimes alternating. Bloating, reflux and persistent burping round out the usual picture. Headache and fatigue occasionally accompany the early phase too, most likely linked to reduced food intake rather than a direct drug effect.
The NHS medicines page for semaglutide lists these in detail alongside practical self-care steps, it is worth bookmarking from day one. Eating smaller portions, avoiding fatty or spicy meals and staying well hydrated all help the system settle. The titration schedule exists precisely to give your body time to adjust at each dose level before moving higher; skipping that process is one of the most common reasons people struggle unnecessarily.
On what the side effects of Wegovy feel like day to day, we go into more practical detail about managing the early period.
For most people, GI side effects are front-loaded. By the time a maintenance dose is established, nausea has often reduced considerably or disappeared altogether. That said, a meaningful minority do continue to experience some degree of digestive sensitivity throughout treatment, particularly after meals that are larger or richer than usual. If you want a clearer picture of what side effects from semaglutide you might reasonably expect, our dedicated page walks through each one in plain terms. The body's signals around fullness become stronger, and ignoring them tends to lead to discomfort.
Hair thinning is a less-discussed but real side effect reported by some people after several months on treatment. It is thought to be a consequence of rapid weight loss and reduced calorie intake rather than semaglutide itself, the same phenomenon seen after bariatric surgery. It generally reverses as the body stabilises.
Injection-site reactions (redness, itching or a small lump at the site) occur occasionally. Rotating between the abdomen, thigh and upper arm usually prevents them building up. Dizziness is reported, particularly if food or fluid intake drops sharply.
For a closer look at how these effects develop over months rather than weeks, our page on the long-term side effects of semaglutide covers the evidence on extended use.
Most side effects of semaglutide are inconvenient rather than dangerous. A small number are not, and it matters to know the difference before you start.
Acute pancreatitis is the one to take most seriously. In January 2026, the MHRA issued a Drug Safety Update highlighting acute pancreatitis as an infrequent but potentially serious risk with GLP-1 medicines including semaglutide. The signal to act is severe, persistent stomach pain (often radiating towards the back, sometimes with vomiting) that does not ease. That warrants a 999 call or immediate A&E attendance, not watchful waiting.
Other situations that need prompt medical attention: signs of a serious allergic reaction (swelling of the face, throat, or tongue; difficulty breathing; rapid heartbeat); gallbladder symptoms such as sudden right-upper-abdominal pain with fever; significant dehydration from prolonged vomiting or diarrhoea that you cannot manage at home; or any thoughts of self-harm or depression that emerge during treatment.
If something feels wrong and you are not sure which category it falls into, call 111. Our patient support team is available seven days a week for questions that fall short of urgent, but for anything urgent, the NHS comes first.
Any suspected side effect can be reported to the MHRA at yellowcard.mhra.gov.uk. This helps the regulator monitor real-world safety, and patients can report directly without going through a prescriber.
Knowing the side-effect profile is only useful alongside knowing whether semaglutide is appropriate for you in the first place. It is not recommended during pregnancy, breastfeeding, or if you are actively trying to conceive. It is not licensed for anyone under 18. A personal or family history of medullary thyroid carcinoma, MEN2 syndrome, or previous pancreatitis episodes are among the conditions that require careful prescriber assessment before treatment could ever be considered.
Questions about safety in people without diabetes come up regularly, our page on whether semaglutide is safe for people without type 2 diabetes addresses the evidence directly. You can also read about the broader risks of taking Wegovy if you want a fuller picture before your consultation. For anyone weighing up their options, our page covering the side effects of taking semaglutide brings together the practical detail you need to make an informed decision.
At nume, a GPhC-registered Independent Prescriber reviews every consultation personally (your health history, current medicines and individual circumstances) before any treatment is approved. If you would like that conversation, start your free consultation and our clinical team will take it from there.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.